Quick answer
No single cause of prostate cancer is known. The risk rises with age, with a father or brother who had the disease, with African ancestry and with some inherited mutations, such as in the BRCA2 gene.1,4 Excess body weight probably raises the risk of advanced disease.7 Vasectomy, an enlarged prostate and prostatitis are not risk factors.11,14 No vitamin or diet has proven effective at preventing the disease, and no medication is recommended for it.1,8
Age
Excluding non-melanoma skin cancer, prostate cancer is the most common cancer in men in Brazil, with 77,920 new cases estimated per year from 2026 to 2028.3
It is rare before age 40, and the risk rises quickly after 50. In the United States, about 6 in 10 cases are found after age 65.4
Family history
Having a father or brother with prostate cancer more than doubles the risk. The risk is higher when the affected relative is a brother, and it rises with several affected relatives, especially when they were diagnosed young.4 In a large American database cited by the European guideline, a family history multiplied the risk of prostate cancer by about 2.3 and the risk of early-onset cancer by about 3.9.1
The European guideline calls prostate cancer hereditary when there are 3 or more cases in a family, cases in 3 successive generations, or 2 or more cases diagnosed before age 55.1
Even so, most men with prostate cancer have no relative with the disease.4 Having no family history does not mean you can skip evaluation.
Genes: BRCA2 and other inherited mutations
Some mutations passed from parents to children raise the risk. Mutations in the BRCA1 and BRCA2 genes together occur in about 0.2% to 0.3% of the population.2 The European guideline describes the main genes this way:1
| Gene | Risk of prostate cancer | What else is known |
|---|---|---|
| BRCA2 | 2.5 to 4.6 times higher1 | Linked to metastases and lower survival from the disease1 |
| BRCA1 | 1.8 to 3.8 times higher up to age 651 | More cases of lethal cancer1 |
| HOXB13 | 3.4 to 7.9 times higher1 | Higher PSA and higher Gleason score at diagnosis1 |
| ATM | 6.3 times higher for metastatic disease1 | More cases of lethal cancer1 |
| Lynch syndrome genes | 3.7 times higher1 | Highest risk in MSH2 mutation carriers1 |
| CHEK2 | 3.3 times higher1 | No further information in the guideline |
In a British study of BRCA2 mutation carriers, the chance of prostate cancer reached 27% by age 75, and the risk of dying from the disease was higher than in the general population.6
The European guideline advises offering genetic testing to men with a known high-risk mutation in the family or several types of cancer on the same side of the family, and suggests testing when several relatives had prostate cancer before age 60. Testing comes with genetic counseling.2
African ancestry
Prostate cancer is more common in men of African ancestry, and it tends to appear earlier.4 In the United States, Black men have 67% more cases and twice the mortality from the disease compared with White men.5
For this reason, the European guideline advises starting evaluation at 45 for men of African ancestry, the same age as for men with a family history.2 The ages for each group are in screening and the prostate exam.
Weight, diet and habits
The World Cancer Research Fund panel concluded that greater body fatness, measured by body mass index and waist size, is probably a cause of advanced prostate cancer. The effect was seen in advanced, high-grade or fatal disease, not in cases overall.7
A systematic review cited by the European guideline linked obesity to more cases of and more deaths from prostate cancer. The link with metabolic syndrome is not clear.1 On diet, the guideline says there are no conclusive data supporting any specific diet to prevent the disease.1
What does not raise the risk or is unproven
| Topic | What studies show |
|---|---|
| Vasectomy | No association with high-grade, advanced or fatal cancer in a meta-analysis11 |
| Enlarged prostate (BPH) | Does not raise the risk of prostate cancer14 |
| Prostatitis | Not a risk factor14 |
| Stress | A link with cancer is not clear13 |
| Ejaculation frequency | In an observational study, 21 or more ejaculations a month were associated with about 20% lower risk than 4 to 7, mostly for low-risk tumors12 |
The ejaculation finding comes from a study that followed men over time. It shows an association and does not prove that ejaculating more prevents cancer.12
Men with an enlarged prostate do not have a higher risk of cancer because of it.14 Evaluation for cancer follows each man's age and risk, as for anyone else.2
Can it be prevented?
The European guideline says no prevention strategy can be recommended.1
- Vitamins and selenium: in the SELECT trial of healthy men, vitamin E increased the risk of prostate cancer by 17%, and selenium had no effect.8
- Finasteride and dutasteride: in the PCPT trial, finasteride reduced the cases found over 7 years by 24.8%, but Gleason 7 to 10 tumors were more common in the group taking the drug.9 After 18 years of follow-up, there was no difference in deaths from the disease.10 Neither drug is approved for prevention by the European Medicines Agency.1 Both are still used to treat an enlarged prostate.
Because there is no proven prevention, the European guideline adjusts the age to start evaluation to each man's risk.2 For men at that age, the next step is a conversation about the PSA test.
How I approach it
In my practice, I start with each man's risk: age, family and previous tests. When there is a family history, I ask who had the disease, at what age, and whether there were other cancers, such as breast or ovarian cancer.
When to see a urologist
- If your father, brother or other relatives had prostate cancer
- If someone in your family has a mutation in BRCA1, BRCA2 or another risk gene
- If there are several cases of breast, ovarian or prostate cancer on the same side of the family
- If you are Black and 45 or older
- From age 50, even without symptoms or cases in the family
Frequently asked questions
What causes prostate cancer?+
No single cause is known. The best-established risk factors are age, family history, African ancestry and some inherited mutations, such as in the BRCA2 gene.1,4
Is prostate cancer hereditary?+
In part. Having a father or brother with the disease more than doubles the risk, and the risk rises with more affected relatives or a diagnosis at a younger age.1,4 Even so, most men with prostate cancer have no family history.4
Does a BRCA2 mutation raise the risk?+
Yes. In a British study, the chance of prostate cancer by age 75 was 27% in BRCA2 mutation carriers, and the tumors tend to be more aggressive.1,6 The European guideline advises starting evaluation at 40 in these men.2
Does obesity raise the risk of prostate cancer?+
Greater body fatness is probably a cause of advanced prostate cancer, according to the World Cancer Research Fund panel.7
Do vitamins or supplements prevent prostate cancer?+
No. In the SELECT trial, vitamin E increased the risk by 17%, and selenium did not protect.8 The European guideline says no prevention strategy has proven effective.1
Does vasectomy cause prostate cancer?+
No. A meta-analysis found no association between vasectomy and high-grade, advanced or fatal prostate cancer.11
Does an enlarged prostate turn into cancer?+
An enlarged prostate (BPH) and prostatitis are not risk factors for prostate cancer.14
Does stress cause prostate cancer?+
It is not clear. Studies of stress and cancer have mixed results, and any link may be indirect, through habits such as smoking or overeating.13
References
- EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. European Association of Urology; 2026. Epidemiology and aetiology chapter. EAU
- EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. European Association of Urology; 2026. Diagnostic evaluation chapter. EAU
- Brazilian National Cancer Institute (INCA). Estimativa 2026-2028: incidência de câncer no Brasil. Rio de Janeiro: INCA; 2026. INCA
- American Cancer Society. Prostate Cancer Risk Factors. 2026. American Cancer Society
- Kratzer TB, Mazzitelli N, Star J, Dahut WL, Jemal A, Siegel RL. Prostate cancer statistics, 2025. CA Cancer J Clin. 2025;75(6):485-497. PubMed
- Nyberg T, Frost D, Barrowdale D, et al. Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study. Eur Urol. 2020;77(1):24-35. PubMed
- World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Expert Report 2018. Diet, nutrition, physical activity and prostate cancer. WCRF/AICR
- Klein EA, Thompson IM Jr, Tangen CM, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011;306(14):1549-1556. PubMed
- Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003;349(3):215-224. PubMed
- Goodman PJ, Tangen CM, Darke AK, et al. Long-Term Effects of Finasteride on Prostate Cancer Mortality. N Engl J Med. 2019;380(4):393-394. PubMed
- Bhindi B, Wallis CJD, Nayan M, et al. The Association Between Vasectomy and Prostate Cancer: A Systematic Review and Meta-analysis. JAMA Intern Med. 2017;177(9):1273-1286. PubMed
- Rider JR, Wilson KM, Sinnott JA, Kelly RS, Mucci LA, Giovannucci EL. Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up. Eur Urol. 2016;70(6):974-982. PubMed
- National Cancer Institute. Stress and Cancer. 2022. NCI
- National Cancer Institute. Understanding Prostate Changes: A Health Guide for Men. 2024. NCI
Would you like to talk about your case?
In the consultation, I go over your tests and your priorities.
Book a consultation
